Published in J Nucl Med on December 12, 2007
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results. Nat Med (2011) 7.82
Multimodality imaging probes: design and challenges. Chem Rev (2010) 2.61
Obtaining adequate surgical margins in breast-conserving therapy for patients with early-stage breast cancer: current modalities and future directions. Ann Surg Oncol (2009) 2.02
Integrin targeting for tumor optical imaging. Theranostics (2011) 1.47
Polymeric nanoparticle-based activatable near-infrared nanosensor for protease determination in vivo. Nano Lett (2009) 1.29
The sodium iodide symporter (NIS) as an imaging reporter for gene, viral, and cell-based therapies. Curr Gene Ther (2012) 1.18
Self-illuminating 64Cu-doped CdSe/ZnS nanocrystals for in vivo tumor imaging. J Am Chem Soc (2014) 1.06
Generation of a highly inducible Gal4-->Fluc universal reporter mouse for in vivo bioluminescence imaging. Proc Natl Acad Sci U S A (2008) 1.04
Nanobody: the "magic bullet" for molecular imaging? Theranostics (2014) 1.04
Monitoring bacterial burden, inflammation and bone damage longitudinally using optical and μCT imaging in an orthopaedic implant infection in mice. PLoS One (2012) 1.00
A three-dimensional finite element model and image reconstruction algorithm for time-domain fluorescence imaging in highly scattering media. Phys Med Biol (2011) 0.99
Initial evaluation of the use of USPIO cell labeling and noninvasive MR monitoring of human tissue-engineered vascular grafts in vivo. FASEB J (2008) 0.99
Excitation spectroscopy in multispectral optical fluorescence tomography: methodology, feasibility and computer simulation studies. Phys Med Biol (2009) 0.99
Highly sensitive in vivo imaging of Trypanosoma brucei expressing "red-shifted" luciferase. PLoS Negl Trop Dis (2013) 0.96
Targeting of alpha(nu)beta(3)-integrins expressed on tumor tissue and neovasculature using fluorescent small molecules and nanoparticles. Nanomedicine (Lond) (2010) 0.95
In vivo imaging and quantification of carbonic anhydrase IX expression as an endogenous biomarker of tumor hypoxia. PLoS One (2012) 0.94
Whole animal imaging. Wiley Interdiscip Rev Syst Biol Med (2010) 0.94
Targeting Acidity in Pancreatic Adenocarcinoma: Multispectral Optoacoustic Tomography Detects pH-Low Insertion Peptide Probes In Vivo. Clin Cancer Res (2015) 0.94
Using ultrasonography to define fetal-maternal relationships: moving from humans to mice. Comp Med (2009) 0.93
Molecular imaging of Cathepsin E-positive tumors in mice using a novel protease-activatable fluorescent probe. Mol Biosyst (2011) 0.89
Multimodality and nanoparticles in medical imaging. Dalton Trans (2011) 0.89
Bioluminescence imaging of stem cell-based therapeutics for vascular regeneration. Theranostics (2012) 0.88
Monitoring of xenograft tumor growth and response to chemotherapy by non-invasive in vivo multispectral fluorescence imaging. PLoS One (2012) 0.88
Genetically engineered oncolytic Newcastle disease virus effectively induces sustained remission of malignant pleural mesothelioma. Mol Cancer Ther (2010) 0.88
[In vivo imaging of retinal cell apoptosis following acute light exposure]. Ophthalmologe (2010) 0.88
A novel luciferase fusion protein for highly sensitive optical imaging: from single-cell analysis to in vivo whole-body bioluminescence imaging. Anal Bioanal Chem (2014) 0.87
Animal models and molecular imaging tools to investigate lymph node metastases. J Mol Med (Berl) (2011) 0.87
Visualization, imaging and new preclinical diagnostics in radiation oncology. Radiat Oncol (2014) 0.86
Noninvasive near-infrared live imaging of human adult mesenchymal stem cells transplanted in a rodent model of Parkinson's disease. Int J Nanomedicine (2012) 0.86
Dual-contrast dynamic MRI-DOT for small animal imaging. Technol Cancer Res Treat (2010) 0.85
A new experimental model for assessing drug efficacy against Trypanosoma cruzi infection based on highly sensitive in vivo imaging. J Biomol Screen (2014) 0.85
Detection and delineation of oral cancer with a PARP1 targeted optical imaging agent. Sci Rep (2016) 0.85
Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2011) 0.84
Potential targets for molecular imaging of apoptosis resistance in hepatocellular carcinoma. Biomed Imaging Interv J (2011) 0.84
Near-infrared fluorescence molecular imaging of amyloid beta species and monitoring therapy in animal models of Alzheimer's disease. Proc Natl Acad Sci U S A (2015) 0.83
Imaging strategies for tissue engineering applications. Tissue Eng Part B Rev (2014) 0.83
In vivo imaging using polymeric nanoparticles stained with near-infrared chemiluminescent and fluorescent squaraine catenane endoperoxide. Chem Commun (Camb) (2013) 0.83
Intravital microscopy in the mouse dorsal chamber model for the study of solid tumors. Am J Cancer Res (2011) 0.83
Molecular Imaging of Proteases in Cancer. Cancer Growth Metastasis (2009) 0.81
Label-free phenotypic profiling identified D-luciferin as a GPR35 agonist. PLoS One (2012) 0.81
Progress on the diagnosis and evaluation of brain tumors. Cancer Imaging (2013) 0.81
Gradient-Based Algorithm for Determining Tumor Volumes in Small Animals Using Planar Fluorescence Imaging Platform. Tomography (2016) 0.80
Novel model for basaloid triple-negative breast cancer: behavior in vivo and response to therapy. Neoplasia (2012) 0.80
Imaging stem cell-derived persistent foci after in vivo selection of lentiviral MGMT-P140K transduced murine bone marrow cells. Mol Ther (2011) 0.79
Longitudinal molecular imaging with single cell resolution of disseminated ovarian cancer in mice with a LED-based confocal microendoscope. Mol Imaging Biol (2011) 0.79
Spectroscopy to improve identification of vulnerable plaques in cardiovascular disease. Int J Cardiovasc Imaging (2009) 0.79
Metabolic response of prostate cancer to nicotinamide phophoribosyltransferase inhibition in a hyperpolarized MR/PET compatible bioreactor. Prostate (2015) 0.79
Utilizing the Multiradionuclide Resolving Power of SPECT and Dual Radiolabeled Single Molecules to Assess Treatment Response of Tumors. Mol Imaging Biol (2015) 0.78
In vivo near-infrared imaging for the tracking of systemically delivered mesenchymal stem cells: tropism for brain tumors and biodistribution. Int J Nanomedicine (2015) 0.78
Visualization of molecular composition and functionality of cancer cells using nanoparticle-augmented ultrasound-guided photoacoustics. Photoacoustics (2015) 0.78
New researches and application progress of commonly used optical molecular imaging technology. Biomed Res Int (2014) 0.78
In vitro and in vivo analysis of indocyanine green-labeled panitumumab for optical imaging-a cautionary tale. Bioconjug Chem (2014) 0.77
Imaging Myocardial Ischemia and Reperfusion Injury via Cy5.5-Annexin V. Nucl Med Mol Imaging (2012) 0.77
Nanoparticle-facilitated functional and molecular imaging for the early detection of cancer. Front Mol Biosci (2014) 0.77
Myocardial infarct size and area at risk assessment in mice. Exp Clin Cardiol (2012) 0.77
Combined in vivo optical and µCT imaging to monitor infection, inflammation, and bone anatomy in an orthopaedic implant infection in mice. J Vis Exp (2014) 0.76
Tissue-simulating phantoms for assessing potential near-infrared fluorescence imaging applications in breast cancer surgery. J Vis Exp (2014) 0.76
Luciferase fragment complementation imaging in preclinical cancer studies. Oncoscience (2014) 0.76
Molecular Imaging in Genetic Medicine. Cureus (2016) 0.76
Molecular and functional imaging of invasion and metastasis: windows into the metastatic cascade. Cancer Biomark (2010) 0.76
Molecular imaging in tumor angiogenesis and relevant drug research. Int J Biomed Imaging (2011) 0.75
Optical imaging: skin cancer imaging. J Nucl Med (2008) 0.75
Quantified ultrasound elastography in the assessment of cutaneous carcinoma. Br J Radiol (2015) 0.75
Nanogels as imaging agents for modalities spanning the electromagnetic spectrum. Mater Horiz (2015) 0.75
A fast and effective determination of the biodistribution and subcellular localization of fluorescent immunoliposomes in freshly excised animal organs. BMC Biotechnol (2017) 0.75
High-resolution optical molecular imaging of changes in choline metabolism in oral neoplasia. Transl Oncol (2013) 0.75
Coupling CDH17 and CLDN18 markers for comprehensive membrane-targeted detection of human gastric cancer. Oncotarget (2016) 0.75
Crimson carrier, a long-acting contrast agent for in vivo near-infrared imaging of injured and diseased muscle. Muscle Nerve (2010) 0.75
Galactose substituted zinc phthalocyanines as near infrared fluorescence probes for liver cancer imaging. J Mater Sci Mater Med (2012) 0.75
Engineering of monobody conjugates for human EphA2-specific optical imaging. PLoS One (2017) 0.75
CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res (2004) 4.53
CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc Natl Acad Sci U S A (2007) 3.85
Near-infrared fluorescent proteins. Nat Methods (2010) 2.52
Imaging 26S proteasome activity and inhibition in living mice. Nat Med (2003) 2.04
Microfluidic endothelium for studying the intravascular adhesion of metastatic breast cancer cells. PLoS One (2009) 1.87
TLR3 increases disease morbidity and mortality from vaccinia infection. J Immunol (2008) 1.26
Microfluidic platform for chemotaxis in gradients formed by CXCL12 source-sink cells. Integr Biol (Camb) (2010) 1.17
Monitoring serial changes in circulating human breast cancer cells in murine xenograft models. Cancer Res (2008) 1.09
In Vivo Monitoring of Multiple Circulating Cell Populations Using Two-photon Flow Cytometry. Opt Commun (2008) 1.02
Murine alveolar macrophages limit replication of vaccinia virus. Virology (2007) 1.02
Protective effect of Toll-like receptor 4 in pulmonary vaccinia infection. PLoS Pathog (2008) 1.02
Type I interferon regulates respiratory virus infected dendritic cell maturation and cytokine production. Viral Immunol (2007) 1.00
Noninvasive imaging reveals inhibition of ovarian cancer by targeting CXCL12-CXCR4. Neoplasia (2011) 1.00
Secreted CXCL12 (SDF-1) forms dimers under physiological conditions. Biochem J (2012) 0.95
Development of a baited oral vaccine for use in reservoir-targeted strategies against Lyme disease. Vaccine (2011) 0.94
NanoLuc reporter for dual luciferase imaging in living animals. Mol Imaging (2013) 0.93
Luciferase protein complementation assays for bioluminescence imaging of cells and mice. Methods Mol Biol (2011) 0.91
Polymeric Aqueous Biphasic System Rehydration Facilitates High Throughput Cell Exclusion Patterning For Cell Migration Studies. Adv Funct Mater (2011) 0.89
Carboxy-terminus of CXCR7 regulates receptor localization and function. Int J Biochem Cell Biol (2012) 0.89
Imaging CXCL12-CXCR4 signaling in ovarian cancer therapy. PLoS One (2013) 0.88
Targeted non-covalent self-assembled nanoparticles based on human serum albumin. Biomaterials (2011) 0.88
In vitro and in vivo characterization of a dual-function green fluorescent protein--HSV1-thymidine kinase reporter gene driven by the human elongation factor 1 alpha promoter. Mol Imaging (2003) 0.86
Extended cavity laser enhanced two-photon flow cytometry. J Biomed Opt (2008) 0.83
Cell-based and in vivo spectral analysis of fluorescent proteins for multiphoton microscopy. J Biomed Opt (2012) 0.83
Host-derived CD8+ dendritic cells are required for induction of optimal graft-versus-tumor responses after experimental allogeneic bone marrow transplantation. Blood (2013) 0.83
Transfer, imaging, and analysis plate for facile handling of 384 hanging drop 3D tissue spheroids. J Lab Autom (2013) 0.82
Longitudinal molecular imaging with single cell resolution of disseminated ovarian cancer in mice with a LED-based confocal microendoscope. Mol Imaging Biol (2011) 0.79
Analysis of human cellular retinol-binding protein II promoter during enterocyte differentiation. Am J Physiol Gastrointest Liver Physiol (2002) 0.78
Allosteric peptide regulators of chemokine receptors CXCR4 and CXCR7. Biochem Pharmacol (2013) 0.76
CXCR4-Targeted Nanocarriers for Triple Negative Breast Cancers. Biomacromolecules (2015) 0.76
Correction: Cell, Isoform, and Environment Factors Shape Gradients and Modulate Chemotaxis. PLoS One (2017) 0.75
Imaging Reporters for Proteasome Activity Identify Tumor- and Metastasis-Initiating Cells. Mol Imaging (2015) 0.75